Pioglitazone attenuates progression of aortic valve calcification via down-regulating receptor for advanced glycation end products
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Receptor for advanced glycation end products (RAGE) is associated with inflammation and the progression of cardiovascular diseases. The current study tested the hypothesis that RAGE is involved in the pathogenesis of aortic valve (AV) calcification. Pioglitazone attenuated AV calcification in experimental hypercholesterolemic rabbits via down-regulation of RAGE. Male New Zealand rabbits weighing 2.5-3.0 kg were randomly divided into three groups: control group, high cholesterol + vitamin D(2) (HC + vitD(2)) group and HC + vitD(2) supplemented with pioglitazone group. Compared with HC + vitD(2) group, pioglitazone significantly inhibited the progression of AV calcification assessed by echocardiography. HC + vitD(2) diet markedly increased RAGE expression, oxidative stress, inflammatory cells infiltration and osteopontin expression. These changes were also significantly attenuated by administration of pioglitazone. Cultured porcine aortic valve interstitial cells (VICs) were used as in vitro model. We found that advanced glycation end products of bovine serum albumin markedly increased the expression of RAGE, induced high levels of production of pro-inflammatory cytokines and promoted osteoblastic differentiation of VICs. However, these effects were found to be remarkably suppressed by siRNA silencing of RAGE and pioglitazone as well. Our data provide evidence that RAGE activation-induced inflammation promotes AV calcification in hypercholesterolemic rabbits, which can be attenuated by pioglitazone treatment. This beneficial effect is associated with remarkable down-regulation of RAGE expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, pioglitazone, a PPARγ agonist, has been shown to reduce aortic valve calcification in mice, rabbit and swine models.43,45,46”
From Transcriptomic signatures of calcific aortic valve stenosis severity in human tricuspid and bicuspid aortic valves (2025) · cites this paper as [45]
Citations
Cites
Burden of valvular heart diseases: a population-based study
Nkomo, V. T., Gardin, J. M., Skelton, T. N., Gottdiener, J. S., Scott, C. G., & Enriquez-Sarano, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69208-8 · Cited by 4,881 · cited 1×
“8 % of adults over 75 years old have some degree of AV calcification [5, 34], and up to 25 % of adults over 65 have valvular sclerosis [3].”
BackgroundThe peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525 · cited 1×
“PPARc agonists possess anti-inflammatory and anti-oxidant properties [40].”
BackgroundBonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O'Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,257
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541 · cited 1×
“Receptor for advanced glycation end products (RAGE) is a multi-ligand receptor expressed in a range of cell types, including endothelial, smooth muscle, mesangial and mononuclear cells [6, 33].”
BackgroundOtto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O'Brien, K. D. (1994) · Circulation · doi:10.1161/01.cir.90.2.844 · Cited by 1,315 · cited 2×
“that AV calcification has many features characteristic of an active pathobiological process akin to atherosclerosis, including chronic inflammation, endothelial dysfunction, lipoprotein deposition and extracellular matrix remodeling [36, 37].”
Background2006 WRITING COMMITTEE MEMBERS, Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,114
Rajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.006767 · Cited by 842 · cited 1×
“Transition from VICs to myofibroblasts is a critical step in valvular pathology [39].”
BackgroundBrett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed · Cited by 780
Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes · doi:10.2337/db07-1808 · Cited by 407 · cited 1×
“Strategies targeting to inactivate RAGE promote plaque stabilization and inhibit the progression of atherosclerotic changes [29, 41, 44].”
BackgroundVascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
Harja, E., Bu, D.-X., Hudson, B. I., Chang, J. S., Shen, X., Hallam, K., Kalea, A. Z., Lu, Y., Rosario, R. H., Oruganti, S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32703 · Cited by 364 · cited 1×
“Previous studies have indicated that the vascular and inflammatory stresses mediated by interaction between RAGE and its ligands, such as AGEs, play a central role in the development of accelerated atherosclerosis [13].”
BackgroundOlsson, M., Dalsgaard, C.-J., Haegerstrand, A., Rosenqvist, M., Rydén, L., & Nilsson, J. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90606-8 · Cited by 307 · cited 2×
“that AV calcification has many features characteristic of an active pathobiological process akin to atherosclerosis, including chronic inflammation, endothelial dysfunction, lipoprotein deposition and extracellular matrix remodeling [36, 37].”
BackgroundAl-Aly, Z., Shao, J.-S., Lai, C.-F., Huang, E., Cai, J., Behrmann, A., Cheng, S.-L., & Towler, D. A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.153668 · Cited by 307 · cited 1×
“The role of TNF-a in inflammation-induced calcification has been confirmed, as TNF-a neutralizing antibody, infliximab, inhibits aortic BMP2-Msx-Wnt calcification cascade in Ldlr mice [1].”
BackgroundRAGE (receptor for advanced glycation end products): a central player in the inflammatory response
Chavakis, T., Bierhaus, A., & Nawroth, P. P. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.08.004 · Cited by 301 · cited 1×
“Observations and experimental evidence strongly suggest that RAGE signaling results in profound inflammation [9, 26].”
BackgroundPathogenesis of Calcific Aortic Valve Disease: A Disease Process Comes of Age (and a Good Deal More)
O’Brien, K. D. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000227513.13697.ac · Cited by 295 · cited 1×
“BMP and Wnt/b-catenin signaling pathways have been reported to be associated with AV calcification [35].”
BackgroundKaden, J. J., Dempfle, C.-E., Grobholz, R., Tran, H.-T., Kılıç, R., Sarıkoç, A., Brueckmann, M., Vahl, C., Hagl, S., Haase, K. K., et al. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00284-3 · Cited by 272 · cited 1×
“Inflammation-associated molecules, IL-1b, 5-lipoxygenase, MCP-1, TNF-a have also been identified in calcified valves and they have been correlated with the severity of AV calcification [22, 23, 32].”
BackgroundManiati, E., Bossard, M., Cook, N., Candido, J. B., Emami-Shahri, N., Nedospasov, S. A., Balkwill, F. R., Tuveson, D. A., & Hagemann, T. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45797 · Cited by 248 · cited 1×
“However, there are data also supporting a crosstalk between the canonical NF-jB and Notch signaling pathways inhibits PPARc expression and promotes pancreatic cancer progression [30].”
BackgroundLoke, Y. K., Kwok, C. S., & Singh, S. (2011) · BMJ · doi:10.1136/bmj.d1309 · Cited by 245 · cited 1×
“However, compared with rosiglitazone, pioglitazone are less prone to induce heart failure [11, 28].”
BackgroundInflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis
Kaden, J. J., Dempfle, C.-E., Grobholz, R., Fischer, C. S., Vocke, D. C., Kılıç, R., Sarıkoç, A., Piñol, R., Hagl, S., Lang, S., et al. (2005) · Cardiovascular Pathology · doi:10.1016/j.carpath.2005.01.002 · Cited by 244 · cited 1×
“Inflammation-associated molecules, IL-1b, 5-lipoxygenase, MCP-1, TNF-a have also been identified in calcified valves and they have been correlated with the severity of AV calcification [22, 23, 32].”
BackgroundLiberman, M., Bassi, E., Martinatti, M. K., Lario, F. C., Wosniak, J., Pomerantzeff, P. M. A., & Laurindo, F. R. M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.156745 · Cited by 225 · cited 2×
“Echocardiographic data and related calculations were performed by an experienced operator blind to the assignments as previously described [25].”
BackgroundMethodInduction of local angiotensin II-producing systems in stenotic aortic valves
Helske, S., Lindstedt, K. A., Laine, M., Mäyränpää, M., Werkkala, K., Lommi, J., Turto, H., Kupari, M., & Kovanen, P. T. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.054 · Cited by 221 · cited 1×
“Normal AV are devoid of inflammatory cells, but, calcified valves have large numbers of accumulated cells including macrophages, T lymphocytes and mast cells [14, 36, 37, 45].”
BackgroundHernandez, A. V., Usmani, A., Rajamanickam, A., & Moheet, A. (2011) · American Journal Cardiovascular Drugs · doi:10.2165/11587580-000000000-00000 · Cited by 200 · cited 1×
“Previous studies suggested that thiazolidinediones, used for the treatment of patients with type 2 diabetes mellitus (DM2), are associated with an increased incidence of heart failure [15].”
BackgroundRAGE signaling in inflammation and arterial aging
Lin, L. (2009) · Frontiers in Bioscience · doi:10.2741/3315 · Cited by 192 · cited 1×
“The associations among RAGE, inflammation and arterial calcification have been well documented [8, 16, 27].”
BackgroundTanikawa, T., Okada, Y., Tanikawa, R., & Tanaka, Y. (2009) · Journal of Vascular Research · doi:10.1159/000226225 · Cited by 191 · cited 3×
“Activation of RAGE by AGEs and adenovirus transfection also induced osteoblastic differentiation of vascular SMCs [43, 46].”
BackgroundPrince, M., Banerjee, C., Javed, A., Green, J., Lian, J. B., Stein, G. S., Bodine, P. V. N., & Komm, B. S. (2001) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010301)80:3<424::aid-jcb160>3.0.co;2-6 · Cited by 185 · cited 1×
“with AV calcification [21], and Runx2 is an essential transcription factor associated with osteoblast differentiation [38].”
BackgroundExperimental aortic valve stenosis in rabbits
Drolet, M., Arsenault, M., & Couët, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00090-1 · Cited by 158 · cited 1×
“This is consistent with previous observations [10].”
Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
Kaden, J. J., Bickelhaupt, S., Grobholz, R., Vahl, C. F., Hagl, S., Brueckmann, M., Haase, K. K., Dempfle, C.-E. H., & Borggrefe, M. M. (2004) · PubMed · Cited by 148
Volz, H. C., Laohachewin, D., Seidel, C., Lasitschka, F., Keilbach, K., Wienbrandt, A. R., Andrassy, J., Bierhaus, A., Kaya, Z., Katus, H. A., et al. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0250-z · Cited by 145 · cited 2×
“RAGE is a member of the immunoglobulin superfamily which is able to bind to a chemically diverse range of AGEs and other non-AGE ligands, including high-mobility group box-1 protein, S100/calgranulins and b-sheet fibrils [47, 48].”
BackgroundYu, Z., Seya, K., Daitoku, K., Motomura, S., Fukuda, I., & Furukawa, K. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.177915 · Cited by 145 · cited 1×
“In addition, TNF-a accelerates the calcification of VICs from patients with AV calcification [51].”
BackgroundLi, L. (2006) · PubMed · Cited by 141
Peroxisome Proliferator-Activated Receptor γ: Implications for Cardiovascular Disease
Hsueh, W. A., & Bruemmer, D. (2004) · Hypertension · doi:10.1161/01.hyp.0000113626.76571.5b · Cited by 137 · cited 1×
“Peroxisome proliferator-activated receptor c (PPARc), a nuclear receptor, is highly expressed in all cells involved in vascular pathologies, including macrophages, endothelial cells, and smooth muscle cells (SMCs) [17].”
BackgroundThiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products
Marx, N., Walcher, D., Ivanova, N., Rautzenberg, K., Jung, A., Friedl, R., Hombach, V., de Caterina, R., Basta, G., Wautier, M.-P., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2662 · Cited by 137 · cited 2×
“[31] reported that rosiglitazone and pioglitazone diminished RAGE protein expression in human endothelial cells, decreasing AGE-BSA and b-amyloid-induced MCP-1 production.”
BackgroundResultHMGB1: the missing link between diabetes mellitus and heart failure
Volz, H. C., Seidel, C., Laohachewin, D., Kaya, Z., Müller, O. J., Pleger, S. T., Lasitschka, F., Bianchi, M. E., Remppis, A., Bierhaus, A., et al. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0114-3 · Cited by 122 · cited 1×
“RAGE is a member of the immunoglobulin superfamily which is able to bind to a chemically diverse range of AGEs and other non-AGE ligands, including high-mobility group box-1 protein, S100/calgranulins and b-sheet fibrils [47, 48].”
BackgroundNagy, E., Andersson, D. C., Caidahl, K., Eriksson, M. J., Eriksson, P., Franco-Cereceda, A., Hansson, G. K., & Bäck, M. (2011) · Circulation · doi:10.1161/circulationaha.110.966846 · Cited by 112 · cited 1×
“Inflammation-associated molecules, IL-1b, 5-lipoxygenase, MCP-1, TNF-a have also been identified in calcified valves and they have been correlated with the severity of AV calcification [22, 23, 32].”
BackgroundKatz, R., Budoff, M. J., Takasu, J., Shavelle, D. M., Bertoni, A., Blumenthal, R. S., Ouyang, P., Wong, N. D., & O'Brien, K. D. (2009) · Diabetes · doi:10.2337/db08-1515 · Cited by 112 · cited 1×
“Previous studies have shown that metabolic syndrome and diabetes are associated with increased risks of the development of AV calcification [24], and these patients demonstrate significantly increased levels of advanced glycation end products (AGEs) in plasma and tissues.”
BackgroundHofmann Bowman, M. A., Gawdzik, J., Bukhari, U., Husain, A. N., Toth, P. T., Kim, G., Earley, J., & McNally, E. M. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.217745 · Cited by 111 · cited 2×
“In contrast, pretreatment with soluble RAGE, which prevents activation of cell surface receptors such as RAGE, significantly attenuated the expression of osteoblastic genes [16].”
BackgroundSun, L., Ishida, T., Yasuda, T., Kojima, Y., Honjo, T., Yamamoto, Y., Yamamoto, H., Ishibashi, S., Hirata, K.-I., & Hayashi, Y. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp036 · Cited by 109 · cited 1×
“Strategies targeting to inactivate RAGE promote plaque stabilization and inhibit the progression of atherosclerotic changes [29, 41, 44].”
BackgroundThe potential effects of anti-diabetic medications on myocardial ischemia–reperfusion injury
Ye, Y., Perez-Polo, J. R., Aguilar, D. A., & Birnbaum, Y. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0216-6 · Cited by 106 · cited 1×
“Previous studies have already shown the protective effect against some cardiovascular pathology [4, 18, 50].”
ResultPorcine cardiac valvular subendothelial cells in culture: Cell isolation and growth characteristics1
JOHNSON, C., HANSON, M., & Helgeson, S. C. (1987) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(87)80529-1 · Cited by 100 · cited 1×
“Porcine aortic VICs were isolated from AV leaflets of pigs from a local abattoir using collagenase digestion as previously described [19, 42].”
MethodWang, K., Zhou, Z., Zhang, M., Fan, L., Forudi, F., Zhou, X., Qu, W., Lincoff, A. M., Schmidt, A. M., Topol, E. J., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.095125 · Cited by 97 · cited 3×
“Accumulating data indicate that PPARc agonists can down-regulate the expression of RAGE both in vitro and in vivo [18, 49].”
BackgroundResultSuga, T., Iso, T., Shimizu, T., Tanaka, T., Yamagishi, S., Takeuchi, M., Imaizumi, T., & Kurabayashi, M. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7120 · Cited by 94
Insights into the use of biomarkers in calcific aortic valve disease.
Beckmann, E., Grau, J. B., Sainger, R., Poggio, P., & Ferrari, G. M. (2010) · PubMed · Cited by 82
Ihm, S., Chang, K., Kim, H.-Y., Baek, S. H., Youn, H., Seung, K., & Kim, J. (2009) · Basic Research in Cardiology · doi:10.1007/s00395-009-0071-x · Cited by 78 · cited 3×
“Previous studies have already shown the protective effect against some cardiovascular pathology [4, 18, 50].”
BackgroundResultJoner, M., Farb, A. A., Cheng, Q., Finn, A. V., Acampado, E., BURKE, A. P., Skorija, K., Creighton, W., Kolodgie, F. D., Gold, H. K., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251021.28725.e8 · Cited by 74 · cited 1×
“[20] demonstrated that oral administration of pioglitazone suppressed in-stent neointimal growth by limiting local inflammatory pathways.”
BackgroundSyväranta, S., Helske, S., Laine, M., Lappalainen, J., Kupari, M. M., Mäyränpää, M. I., Lindstedt, K. A., & Kovanen, P. T. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.198267 · Cited by 70 · cited 1×
“Normal AV are devoid of inflammatory cells, but, calcified valves have large numbers of accumulated cells including macrophages, T lymphocytes and mast cells [14, 36, 37, 45].”
BackgroundSpeidl, W. S., Cimmino, G., Ibanez, B., Elmariah, S., Hutter, R., Garcia, M. J., Fuster, V., Goldman, M. E., & Badimon, J. J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq064 · Cited by 60 · cited 2×
“MCP-1 has also been associated with macrophages infiltration in a rabbit model of AV calcification model [42].”
BackgroundMethodLu, Y., Qin, W., Shen, T., Dou, L., Man, Y., Wang, S., Xiao, C., & Li, J. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.8870 · Cited by 47 · cited 1×
“Strategies targeting to inactivate RAGE promote plaque stabilization and inhibit the progression of atherosclerotic changes [29, 41, 44].”
BackgroundBirnbaum, Y., Long, B., Qian, J., Perez-Polo, J. R., & Ye, Y. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0162-3 · Cited by 46 · cited 1×
“Previous studies have already shown the protective effect against some cardiovascular pathology [4, 18, 50].”
ResultHanefeld, M., Pfützner, A., Forst, T. M., Kleine, I., & Fuchs, W. A. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-65 · Cited by 45
Okahashi, N., Murase, Y., Koseki, T., Sato, T., Yamato, K., & Nishihara, T. (2000) · Journal of Cellular Biochemistry · doi:10.1002/1097-4644(20010301)80:3<360::aid-jcb90>3.0.co;2-x · Cited by 42
Gallagher, A. M., Smeeth, L. L., Seabroke, S., Leufkens, H. G. M., & van Staa, T. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028157 · Cited by 39 · cited 1×
“However, compared with rosiglitazone, pioglitazone are less prone to induce heart failure [11, 28].”
BackgroundArterial Calcification Is Driven by RAGE in Enpp1–/– Mice
Cecil, D. L., & Terkeltaub, R. A. (2010) · Journal of Vascular Research · doi:10.1159/000318805 · Cited by 38 · cited 1×
“The associations among RAGE, inflammation and arterial calcification have been well documented [8, 16, 27].”
BackgroundBasta, G., Corciu, A. I., Vianello, A., Turco, S. D., Foffa, I., Navarra, T., Chiappino, D., Berti, S. L., & Mazzone, A. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.029 · Cited by 35 · cited 1×
“In addition, circulating soluble RAGEs, the extracellular ligand binding domain of RAGE, which prevent AGEs from binding to tissue RAGEs, were found to be significantly lower in the plasma of patients with AV calcification [2].”
Background(2009) · Diabetes · doi:10.2337/db09-er08b · Cited by 19
Cai, Z., Li, F., Peng, C., Li, H., Yiqiang, Z., Liu, Z., & Qu, S. (2010) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-010-0541-2 · Cited by 5 · cited 1×
“RNA was isolated and reverse transcribed to cDNA as previously described [7].”
MethodSelf-citation
Cited by
Aldini, G., Vistoli, G., Stefek, M., Chondrogianni, N., Grune, T., Sereikaite, J., Sadowska-Bartosz, I., & Bartosz, G. (2013) · Free Radical Research · doi:10.3109/10715762.2013.792926 · Cited by 150
“RAGE activation-induced inflammation promotes aortic valve calcification in hypercholesterolemic rabbits, which can be attenuated by pioglitazone treatment [508].”
BackgroundInfluentialRethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug
Nesti, L., Tricò, D., Mengozzi, A., & Natali, A. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01294-7 · Cited by 124
“It also reduced aortic valve calcification in non-diabetic, hypercholesterolemic rats [47].”
BackgroundEvaluating Medical Therapy for Calcific Aortic Stenosis
Lindman, B. R., Sukul, D., Dweck, M. R., Madhavan, M. V., Arsenault, B. J., Coylewright, M., Merryman, W. D., Newby, D. E., Lewis, J., Harrell, F. E., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.1367 · Cited by 111
Fibrocalcific Aortic Valve Disease: Opportunity to Understand Disease Mechanisms Using Mouse Models
Weiss, R. M., Miller, J. D., & Heistad, D. D. (2013) · Circulation Research · doi:10.1161/circresaha.113.300153 · Cited by 102
Kopytek, M., Ząbczyk, M., Mazur, P. K., Undas, A., & Natorska, J. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01068-7 · Cited by 97
Metadata
- Authors
- Li, F., Cai, Z., Chen, F., Shi, X., Zhang, Q., Chen, S., Shi, J., Wang, D. W., & Dong, N.
- Affiliations
- Wuhan Union Hospital (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
- Henan Provincial People's Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Tongji Hospital (CN)
- Corresponding author
- Wang, Dao Wen
- Dong, Nianguo
- Venue
- Basic Research in Cardiology
- Published
- 2012-10-16
- Volume
- 107
- Issue
- 6
- Pages
- 306-306
- ISSN
- 0003-9217 (ISSN-L)
- 0300-8428
- 1435-1803
- OpenAlex
- W2043671515
- Cited by
- 67
- References
- 53
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 8 · 2020: 6 · 2018: 4 · 2017: 3 · 2016: 6 · 2015: 5 · 2014: 10 · 2013: 5
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Basic Research in Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Keywords
- pioglitazone, aortic valve calcification, receptor for advanced glycation end products, advanced glycation end products, hypercholesterolemia, vitamin D2, oxidative stress, inflammation, osteopontin, aortic valve interstitial cells, osteogenic differentiation, inflammatory cytokines, siRNA knockdown
- MeSH terms
- Receptor for Advanced Glycation End Products, Pioglitazone, Animals, Aortic Valve, Aortic Valve Stenosis, Calcinosis, Cell Differentiation, Drug Evaluation, Preclinical, Echocardiography, Hypoglycemic Agents, Immunohistochemistry, Male, Osteoblasts, Rabbits, Receptors, Immunologic, Down-Regulation, Thiazolidinediones, PPAR gamma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.